Shuttle Pharmaceuticals Holdings (SHPH) Convertible Debt (2023 - 2025)

Shuttle Pharmaceuticals Holdings' Convertible Debt history runs 3 years deep, the most recent figure standing at $10.0 million for Q2 2025.

• In Q2 2025, Convertible Debt changed 0.0% year-over-year to $10.0 million; the TTM figure through Jun 2025 stood at $10.0 million (changed 0.0% YoY), while the FY2024 annual figure was $10.0 million, up 7302.53% from the prior year.
• Convertible Debt was $10.0 million for Q2 2025 at Shuttle Pharmaceuticals Holdings, roughly flat from $10.0 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $10.0 million in Q2 2024 to a low of $122309.0 in Q2 2023.
• Historically, Convertible Debt has averaged $6.3 million across 3 years, with a median of $10.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Convertible Debt surged 8076.01% in 2024, then changed 0.0% in 2025.
• A 3-year view of Convertible Debt shows it stood at $135089.0 in 2023, then surged by 7302.53% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025.
• The last three Convertible Debt figures came in at $10.0 million (Q2 2025), $10.0 million (Q1 2025), and $10.0 million (Q4 2024), per Business Quant data.